Track topics on Twitter Track topics that are important to you
Published with kind permission of MEDNOUS Oxford BioMedica Plc said that recent, promising data from an ongoing Phase 1/2 study of its gene therapy, ProSavin, support the therapy’s potential as a treatment for the motor symptoms of Parkinson’s disease. The update was issued on 31 August with the release of the company’s financial results for [...]
Original Article: Oxford BioMedica reports advances in gene therapyNEXT ARTICLE
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase 'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...